https://www.selleckchem.com/products/cb-5339.html
Prognosis of high-risk neuroblastoma (HRN remains poor despite multimodal therapies. Better prediction of survival could help to refine patient stratification and better tailor treatments. We established a mechanistic model of metastasis in HRNB relying on two processes growth and dissemination relying on two patient-specific parameters the dissemination rate μ and the minimal visible lesion size Svis. This model was calibrated using diagnosis values of primary tumor size, lactate dehydrogenase circulating levels, and the meta-iodoben
Like
Comment
Share
